Category: US5171251003

BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex…